P. Arveux and A. Bertaut, ??volutions r??centes de l???incidence du cancer du sein, Archives des Maladies Professionnelles et de l'Environnement, vol.76, issue.1, pp.45-51, 2015.
DOI : 10.1016/j.admp.2014.12.006

R. Rouzier and S. Legoff, Rôle du médecin généraliste dans le suivi du cancer du sein. EMC -Traité Médecine AKOS, janv, vol.2, issue.3, pp.1-5, 2007.

M. Namer and J. Gligorov, La surveillance des cancers du sein après traitement : pourquoi je fais des examens complémentaires ? 27° Journ Société Fr Sénologie Pathol Mammaire Deauville FRA, 2005.

S. Cochet, L. Favet, and A. Sappino, Surveillance following curative therapy for breast cancer]. Rev Médicale Suisse, pp.1258-1260, 2008.

H. Rochefort and J. Rouëssé, Groupe de Travail de la Commission III (Cancérologie) How to reduce the incidence of breast cancer, Bull Académie Natl Médecine. janv, vol.192, issue.1, pp.161-79, 2008.

E. Senkus, S. Kyriakides, S. Ohno, F. Penault-llorca, P. Poortmans et al., Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.26, issue.suppl 5, pp.8-30, 2015.
DOI : 10.1093/annonc/mdv298

. Inca, La situation du cancer en France en 2011, 2011.

. Inca, Les cancers en France -Edition 2014

S. Bouée, P. Grosclaude, A. Alfonsi, V. Florentin, F. Clavel-chapelon et al., Projection of the incidence of breast cancer in France in 2018], Bull Cancer, vol.97, issue.3, pp.293-302, 2010.

A. Antoniou, P. Pharoah, S. Narod, H. Risch, J. Eyfjord et al., Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies, The American Journal of Human Genetics, vol.72, issue.5, pp.1117-1147, 2003.
DOI : 10.1086/375033

N. Boyd, H. Guo, L. Martin, L. Sun, J. Stone et al., Mammographic Density and the Risk and Detection of Breast Cancer, New England Journal of Medicine, vol.356, issue.3, pp.227-263, 2007.
DOI : 10.1056/NEJMoa062790

R. Weir, P. Day, and A. W. , New Zealand Health Technology Assessment Clearing House Risk factors for breast cancer in women: a systematic review of the literature, Christchurch, N.Z.: New Zealand Health Technology Assessment, 2007.

B. Tehard, C. Friedenreich, J. Oppert, and F. Clavel-chapelon, Effect of Physical Activity on Women at Increased Risk of Breast Cancer: Results from the E3N Cohort Study, Cancer Epidemiology Biomarkers & Prevention, vol.15, issue.1, pp.57-64, 2006.
DOI : 10.1158/1055-9965.EPI-05-0603

URL : https://hal.archives-ouvertes.fr/inserm-00107119

. Invs, Taux de participation au programme de dépistage organisé du cancer du sein, pp.2013-2014

C. Hill, Breast cancer screening] Presse Médicale Paris Fr 1983, pp.501-510, 2014.

C. Balu-maestro, C. Chapellier, J. Souci, T. Caramella, and C. Marcotte-bloch, D??pistage du cancer du sein??: quelle imagerie pour quelles femmes???, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.39, issue.1, pp.3-10, 2010.
DOI : 10.1016/j.jgyn.2009.08.001

. Inca, Cancer du sein infiltrant non métastatique ; questions d'actualité, 2012.

J. Tao, K. Visvanathan, and A. Wolff, Long term side effects of adjuvant chemotherapy in patients with early breast cancer, The Breast, vol.24, issue.2, pp.149-153, 2015.
DOI : 10.1016/j.breast.2015.07.035

R. Odermatt, A. Wolfer, and K. Zaman, Endocrine therapy in breast cancer: efficacy and adverse events]. Rev Médicale Suisse, 22 mai, vol.9, issue.387, pp.1090-1094, 2013.

C. Davies, H. Pan, J. Godwin, R. Gray, R. Arriagada et al., Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, The Lancet, vol.381, issue.9869, pp.805-821, 2013.
DOI : 10.1016/S0140-6736(12)61963-1

H. Burstein, S. Temin, H. Anderson, T. Buchholz, N. Davidson et al., Adjuvant Endocrine Therapy for Women With Hormone Receptor???Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update, Journal of Clinical Oncology, vol.32, issue.21, pp.2255-69, 2014.
DOI : 10.1200/JCO.2013.54.2258

J. Emery, Cancer survivorship--the role of the GP, Aust Fam Physician. août, vol.43, issue.8, pp.521-526, 2014.

D. Kerrigan, P. Waters, M. Ryan, M. Irfan, J. Hanaghan et al., Follow-up arrangements for breast cancer patients; is it appropriate to transfer surveillance to general practitioners?, Ir Med J. oct, vol.107, issue.9, pp.273-278, 2014.

E. Grunfeld, D. Mant, P. Yudkin, R. Adewuyi-dalton, D. Cole et al., Routine follow up of breast cancer in primary care: randomised trial, BMJ, vol.313, issue.7058, pp.665-674, 1996.
DOI : 10.1136/bmj.313.7058.665

E. Grunfeld, M. Levine, J. Julian, D. Coyle, B. Szechtman et al., Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care, Journal of Clinical Oncology, vol.24, issue.6, pp.848-55, 2006.
DOI : 10.1200/JCO.2005.03.2235

J. Khatcheressian and T. Smith, Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care, Journal of Clinical Oncology, vol.24, issue.6, pp.835-842, 2006.
DOI : 10.1200/JCO.2005.04.5153

E. Grunfeld, A. Gray, D. Mant, P. Yudkin, R. Adewuyi-dalton et al., Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation, British Journal of Cancer, vol.79, issue.7/8, pp.1227-1260, 1999.
DOI : 10.1038/sj.bjc.6690197

J. Baena-cañada, P. Ramírez-daffós, C. Cortés-carmona, P. Rosado-varela, J. Nieto-vera et al., Follow-up of long-term survivors of breast cancer in primary care versus specialist attention, Family Practice, vol.30, issue.5, pp.525-557, 2013.
DOI : 10.1093/fampra/cmt030

R. Maly, Y. Liu, A. Diamant, and A. Thind, The Impact of Primary Care Physicians on Follow-up Care of Underserved Breast Cancer Survivors, The Journal of the American Board of Family Medicine, vol.26, issue.6, pp.628-664, 2013.
DOI : 10.3122/jabfm.2013.06.120345

E. Warner and J. Weinroth, Family Physician Versus Specialist Care for Breast Cancer Follow-Up, Journal of Clinical Oncology, vol.24, issue.22, pp.3710-3710, 2006.
DOI : 10.1200/JCO.2006.06.8932

E. Grunfeld, R. Fitzpatrick, D. Mant, P. Yudkin, R. Adewuyi-dalton et al., Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial, Br J Gen Pract J R Coll Gen Pract. sept, vol.49, issue.446, pp.705-715, 1999.

B. Miedema, I. Macdonald, and S. Tatemichi, Cancer follow-up care. Patients' perspectives, Can Fam Physician. juill, vol.49, pp.890-895, 2003.

E. Grunfeld, D. Mant, M. Vessey, and R. Fitzpatrick, Specialist and general practice views on routine follow-up of breast cancer patients in general practice, Family Practice, vol.12, issue.1, pp.60-65, 1995.
DOI : 10.1093/fampra/12.1.60

E. Grunfeld, D. Mant, M. Vessey, and P. Yudkin, Evaluating primary care follow-up of breast cancer: Methods and preliminary results of three studies, Annals of Oncology, vol.6, issue.suppl 2, pp.47-52, 1995.
DOI : 10.1093/annonc/6.suppl_2.S47

C. Roorda, A. Berendsen, M. Haverkamp, K. Van-der-meer, and G. De-bock, Discharge of breast cancer patients to primary care at the end of hospital follow-up: A cross-sectional survey, European Journal of Cancer, vol.49, issue.8, pp.1836-1880, 1990.
DOI : 10.1016/j.ejca.2013.01.016

J. Khatcheressian, P. Hurley, E. Bantug, L. Esserman, E. Grunfeld et al., Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update, Journal of Clinical Oncology, vol.31, issue.7, pp.961-966, 2013.
DOI : 10.1200/JCO.2012.45.9859

J. Khatcheressian and C. Swainey, Breast cancer follow-up in the adjuvant setting, Current Oncology Reports, vol.106, issue.1, pp.38-46, 2008.
DOI : 10.1007/s11912-008-0007-x

M. Rojas, E. Telaro, A. Russo, I. Moschetti, L. Coe et al., Follow-up strategies for women treated for early breast cancer, Cochrane Database Syst Rev, vol.4, issue.4, p.1768, 2005.
DOI : 10.1002/14651858.CD001768.pub2

J. Khatcheressian and T. Smith, Symptom-Oriented Follow-Up of Early Breast Cancer ??? as Good as Conventional Control and Sparing Resources, Oncology Research and Treatment, vol.30, issue.8-9, pp.410-412, 2007.
DOI : 10.1159/000105331

I. Sperduti, P. Vici, N. Tinari, T. Gamucci, D. Tursi et al., Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review, Journal of Experimental & Clinical Cancer Research, vol.32, issue.1, p.89, 2013.
DOI : 10.1186/1756-9966-32-89

A. Witteveen, I. Vliegen, G. Sonke, J. Klaase, M. Ijzerman et al., Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients, Breast Cancer Research and Treatment, vol.26, issue.Suppl 2, pp.627-663, 2015.
DOI : 10.1007/s10549-015-3490-4

N. Hiramanek, Breast cancer recurrence: follow up after treatment for primary breast cancer, Postgraduate Medical Journal, vol.80, issue.941, pp.172-178, 2004.
DOI : 10.1136/pgmj.2003.010728

P. Taourel, C. Cyteval, C. Granier, M. Devaux, and A. Suau, Imagerie de la maladie m??tastatique dans le cancer du sein, 2007.
DOI : 10.1007/978-2-287-72615-6_6

B. Cutuli, F. Dalenc, and P. Cottu, Caractéristiques histopathologiques et modalitées thérapeutiques des cancers du sein infiltrants : analyse comparative de deux observatoires nationaux réalisés en, La lettre du Sénologue, vol.45, pp.31-35, 2001.

B. Cutuli, D. Lafontan, B. Lemanski, and C. , Effets secondaires des traitements locorégionaux, 2010.

R. Thomas-maclean, B. Miedema, and S. Tatemichi, Breast cancer-related lymphedema, Can Fam Physician. 10 févr, vol.51, issue.2, p.247, 2005.

J. Mcwayne and S. Heiney, Psychologic and social sequelae of secondary lymphedema, Cancer, vol.25, issue.3, pp.457-66, 2005.
DOI : 10.1002/cncr.21195

F. Clère, Breast cancer-related neuropathic pain : classifiction and managment, La lettre au Senologue. oct, vol.26, 2004.

Z. Longchamp, D. Zaman, K. Aebischer, and N. , Cardiologic follow up of an oncologic patient]. Rev Médicale Suisse. 2 juin, pp.1133-1137, 2010.

P. Heidenreich, S. Hancock, R. Vagelos, B. Lee, and I. Schnittger, Diastolic dysfunction after mediastinal irradiation, American Heart Journal, vol.150, issue.5, pp.977-82, 2005.
DOI : 10.1016/j.ahj.2004.12.026

G. Boutet, Traitement des bouff??es de chaleur apr??s cancer du sein, Gyn??cologie Obst??trique & Fertilit??, vol.40, issue.4, pp.241-54, 2012.
DOI : 10.1016/j.gyobfe.2012.02.015

B. Gerber, A. Krause, H. Müller, T. Reimer, T. Külz et al., Effects of Adjuvant Tamoxifen on the Endometrium in Postmenopausal Women With Breast Cancer: A Prospective Long-Term Study Using Transvaginal Ultrasound, Journal of Clinical Oncology, vol.18, issue.20, pp.3464-70, 2000.
DOI : 10.1200/JCO.2000.18.20.3464

C. Van-poznak, R. Hannon, J. Mackey, M. Campone, J. Apffelstaedt et al., Prevention of Aromatase Inhibitor???Induced Bone Loss Using Risedronate: The SABRE Trial, Journal of Clinical Oncology, vol.28, issue.6, pp.967-75, 2010.
DOI : 10.1200/JCO.2009.24.5902

M. Cepa and C. Vaz, Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors, Acta Reumatol Port. déc, vol.40, issue.4, pp.323-353, 2015.

B. Thürlimann, A. Keshaviah, A. Coates, H. Mouridsen, and L. Mauriac, A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer, Breast International Group (BIG) 1-98 Collaborative Group, pp.2747-57, 2005.

E. Morice and E. Leroyer, Existe-il des éléments prédictifs de l'implication des médecins généralistes dans les thèses de recherche en médecine générale, 2010.

D. Berstein, P. O. Blotiere, F. Bousquet, R. Legal, and L. Silvera, La variabilté des pratiques en médecine générale, 2011.